Tracking An FDA Advisory Panel’s Meeting On J&J’s Covid-19 Vaccine-STAT

Now it’s Johnson & Johnson’s turn. A panel of outside experts is meeting Friday for a third time to consider whether the Food and Drug Administration ought to give an emergency use authorization for a Covid-19 vaccine, this one from J&J. STAT, 02/26/2021

•   Print
•   Email
•   Share
•   Tweet